Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Opinion in Pharmacology|July 20, 2002
CD40-CD40L interaction in Alzheimer's diseaseJun Tan, Terrence Town, Mike MullanNeuromolecular Medicine|October 26, 2005
T-cells in Alzheimer's diseaseTerrence Town, Jun Tan, Richard A Flavell, et al.Journal of Neuropathology and Experimental Neurology|January 22, 2013
Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau miceJoseph-Olubunmi Ojo, Benoit Mouzon, M Banks Greenberg, et al.Acta Neuropathologica Communications|October 20, 2020
Nilvadipine suppresses inflammation via inhibition of P-SYK and restores spatial memory deficits in a mouse model of repetitive mild TBIAlexander Morin, Benoit Mouzon, Scott Ferguson, et al.Frontiers in Aging Neuroscience|October 27, 2018
Treatment With Nilvadipine Mitigates Inflammatory Pathology and Improves Spatial Memory in Aged hTau Mice After Repetitive Mild TBIAlexander Morin, Benoit Mouzon, Scott Ferguson, et al.Scientific Reports|April 13, 2021
A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau miceAlexander Morin, Benoit Mouzon, Scott Ferguson, et al.Brain Research. Molecular Brain Research|May 17, 2005
Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cellsDaniel Paris, Ghania Ait-Ghezala, Venkatarajan S Mathura, et al.The EMBO Journal|February 16, 2002
CD40 is expressed and functional on neuronal cellsJun Tan, Terrence Town, Takashi Mori, et al.Journal of Neuroscience Research|July 19, 2002
p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitroTerrence Town, Joseph Zolton, Reed Shaffner, et al.Journal of Neuroimmunology|November 6, 2002
Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42)Terrence Town, Martina Vendrame, Anant Patel, et al.Pageof 2